WHO Model Prescribing Information: Drugs Used in Skin Diseases
(1997; 132 pages) [French] [Spanish] Voir le document au format PDF
Table des matières
Afficher le documentPreface
Afficher le documentIntroduction
Ouvrir ce répertoire et afficher son contenuParasitic infections
Ouvrir ce répertoire et afficher son contenuInsect and arachnid bites and stings
Ouvrir ce répertoire et afficher son contenuSuperficial fungal infections
Ouvrir ce répertoire et afficher son contenuSubcutaneous fungal infections
Ouvrir ce répertoire et afficher son contenuBacterial infections
Ouvrir ce répertoire et afficher son contenuViral infections
Ouvrir ce répertoire et afficher son contenuEczematous diseases
Ouvrir ce répertoire et afficher son contenuScaling diseases
Ouvrir ce répertoire et afficher son contenuPapulosquamous diseases
Afficher le documentCutaneous reactions to drugs
Ouvrir ce répertoire et afficher son contenuPigmentary disorders
Ouvrir ce répertoire et afficher son contenuPremalignant lesions and malignant tumours
Ouvrir ce répertoire et afficher son contenuPhotodermatoses
Ouvrir ce répertoire et afficher son contenuBullous dermatoses
Afficher le documentAlopecia areata
Afficher le documentUrticaria
Ouvrir ce répertoire et afficher son contenuConditions common in children
Afficher le documentAcne vulgaris
Afficher le documentPruritus
Afficher le documentTropical ulcers
Ouvrir ce répertoire et afficher son contenuAntimicrobial drugs
Ouvrir ce répertoire et afficher son contenuAntifugal drugs
Ouvrir ce répertoire et afficher son contenuAntiseptic agents
Ouvrir ce répertoire et afficher son contenuKeratoplastic and keratolytic agents
Fermer ce répertoireScabicides and pediculicides
Afficher le documentBenzyl benzoate
Afficher le documentLindane
Afficher le documentPermethrin
Ouvrir ce répertoire et afficher son contenuAnti-inflammatory and antipruritic drugs1
Ouvrir ce répertoire et afficher son contenuAntiallergics and drugs used in anaphylaxis
Ouvrir ce répertoire et afficher son contenuUltraviolet radiation-blocking agents (sunscreens)
Ouvrir ce répertoire et afficher son contenuMiscellaneous drugs
Ouvrir ce répertoire et afficher son contenuAnnex
Afficher le documentSelected WHO Publications of Related Interest
Afficher le documentBack cover
 

Benzyl benzoate

Lotion, 25%

General information

Benzyl benzoate is a synthetic compound that is produced from benzoic acid and benzyl alcohol. It is toxic to the ectoparasites Sarcoptes scabiei hominis, Pediculus humanus capitis, P. humanus corporis and Pthirus pubis.

Clinical information

Uses

Treatment of scabies and pediculosis of the head, body and pubic area.

Dosage and administration

All doses are suitable for adults and children.

Scabies:

The lotion should be applied to all skin surfaces, from the scalp to the soles of the feet. Care should be taken to avoid contact with the eyes. It is not necessary to bathe before application. To prevent reinfestation, clothing and bedding should be washed or left outside exposed to the air for 72 hours. The lotion is usually applied once daily at night on 2 consecutive days. This may be followed by a single application at night 3 days later.

All members of the household should be treated simultaneously.

Pediculosis:

The lotion should be applied to the affected area and left for 24 hours before being rinsed off. If necessary, treatment may be repeated after 7 and 14 days.

Contacts should also be treated at the some time.

Contraindications

Known hypersensitivity to benzyl benzoate.

Precautions

Benzyl benzoate should not be applied to acutely inflamed or broken skin.

Use in pregnancy

Benzyl benzoate may be applied safely during pregnancy.

Adverse effects

Irritation of the skin with burning or stinging sensations is common.

Overdosage

Gastric lavage may be of value if undertaken within a few hours of accidental ingestion. If convulsions occur they should be treated with intravenous diazepam. Treatment is otherwise supportive.

Storage

Lotion should be stored in well-closed containers, protected from light.

vers la section précédente vers la section suivante
 

Dernière mise à jour: le 24 avril 2012